Hans Soederlund

Title: The Innovations of Hans Soederlund

Introduction

Hans Soederlund is a notable inventor based in Finland. He has made significant contributions to the fields of immunology and drug testing. His work focuses on developing innovative methods for detecting cannabis use and creating hypoallergenic polypeptides.

Latest Patents

Soederlund's latest patents include a groundbreaking method for detecting cannabis use. This invention involves a binding partner, particularly an antibody fragment that specifically recognizes an antigen-antibody immune complex between anti-THC and THC (tetrahydrocannabinol). The binding partner facilitates a non-competitive homogenous immunoassay for the detection of cannabis use. A test kit comprising this binding partner is also described, with a preferred application for roadside testing of saliva from suspected drivers. Another significant patent is related to the preparation of hypoallergenic candidate polypeptides. This invention provides a method for producing modified allergenic polypeptides for use in immunotherapies. The method modifies allergenic polypeptides so that they cannot form transient dimers. Additionally, the invention includes modified beta-lactoglobulins for use in the immunotherapy of milk allergy.

Career Highlights

Throughout his career, Hans Soederlund has worked with various organizations, including Desentum Oy and Valtion Teknillinen Tutkimuskeskus. His experience in these companies has contributed to his expertise in the field of immunology and drug testing.

Collaborations

Soederlund has collaborated with notable colleagues such as Juha Rouvinen and Kristiina Takkinen. These collaborations have further enhanced his research and development efforts.

Conclusion

Hans Soederlund is an innovative inventor whose work in cannabis detection and hypoallergenic polypeptides has the potential to impact public safety and healthcare. His contributions to these fields demonstrate the importance of innovation in addressing contemporary challenges.